Stablepoint Partners’s CVS Health CVS Stock Holding History

Stablepoint Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.14M	Buy	88,359 +190	+0.2%	+$17K	1.26%	15
2026 Q1	$6.33M	Sell	88,169 -3,782	-4%	-$291K	0.94%	35
2025 Q4	$7.3M	Buy	91,951 +90	+0.1%	+$7.09K	1.14%	20
2025 Q3	$6.93M	Sell	91,861 -7,549	-8%	-$517K	1.1%	22
2025 Q2	$6.86M	Buy	99,410 +1,094	+1%	+$71.7K	1.17%	18
2025 Q1	$6.66M	Buy	98,316 +21,575	+28%	+$1.29M	1.21%	17
2024 Q4	$3.44M	Sell	76,741 -9,108	-11%	-$511K	0.63%	56
2024 Q3	$5.4M	Sell	85,849 -1,476	-2%	-$86.1K	0.98%	34
2024 Q2	$5.38M	Buy	87,325 +12,559	+17%	+$786K	1.04%	27
2024 Q1	$5.96M	Buy	74,766 +2,786	+4%	+$213K	1.21%	17
2023 Q4	$5.68M	Buy	+71,980	New	+$5.12M	1.46%	9

Other funds holding CVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

CAM

Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

Stablepoint Partners's CVS Position: Q2 2026 in Review

Stablepoint Partners increased its CVS Health (CVS) stake by 0.22% in Q2 2026, buying an estimated $17K and bringing the position to 88,359 shares worth $9.14M. The position accounts for 1.26% of the portfolio, ranked #15.

Stablepoint Partners first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 348 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Stablepoint Partners held 88,359 shares of CVS Health worth $9.14M as of Q2 2026.
Stablepoint Partners bought 190 CVS Health shares in Q2 2026, an estimated $17K.
CVS Health made up 1.26% of Stablepoint Partners's portfolio in Q2 2026, its #15 holding.
Stablepoint Partners first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
348 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.